More than 1.89 crore unutilised COVID-19 vaccine doses available with states/UTs: Govt

Over two crore vaccine doses have been administered in the first 72 hours of the implementation of the new revised guidelines of the National COVID-19 Vaccination Programme, the ministry said.

PTI
June 24, 2021 / 03:35 PM IST

Representative image

More than 1.89 crore balance and unutilised COVID-19 vaccine doses are still available with the states and Union territories, the Union health ministry said on Thursday.

Over two crore vaccine doses have been administered in the first 72 hours of the implementation of the new revised guidelines of the National COVID-19 Vaccination Programme, the ministry said.

More than 30 crore (30,33,27,440) vaccine doses have been provided by the Centre to states/UTs so far, through Government of India (free of cost channel) and direct state procurement category.

Of this, the total consumption, including wastages, is 28,43,40,936 doses (according to the data available at 8 am on Thursday), the ministry said.

"More than 1.89 crore (1,89,86,504) balance and unutilised Covid vaccine doses are still available with the states and UTs to be administered."

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

Follow our LIVE blog for latest updates of the novel coronavirus pandemic

"Furthermore, more than 21,05,010 vaccine doses are in the pipeline and will be received by them within the next three days,” the ministry said.

The Union government is committed to accelerating the pace and expanding the scope of COVID-19 vaccination throughout the country.

The new phase of universalisation of COVID-19 vaccination commenced from June 21.

The vaccination drive has been ramped up through availability of more vaccines, advance visibility of vaccine availability to states/UTs for enabling better planning by them, and streamlining the vaccine supply chain, the ministry said.

Under the nationwide vaccination drive, the Centre has been supporting the states/UTs by providing them Covid vaccines free of cost.

In the new phase of the universalisation of the COVID-19 vaccination drive, the Union government will procure and supply (free of cost) 75 percent of the vaccines being produced by vaccine manufacturers in the country to states/UTs, it added.

Follow our full coverage of the coronavirus pandemic here.
PTI
TAGS: #coronavirus #COVID-19 vaccine #Current Affairs #Health #India
first published: Jun 24, 2021 03:35 pm